Stock Market Live Updates: Indian indices pared morning gains to turn flat dragged mainly by losses in banking, metals and pharma stocks.
Read more: Stock Market Live Updates: Sensex pares gains, turns flat, Nifty below 15600; banks, metals drag
Monday, May 31, 2021
Pharma Reviews: Stock Market Live Updates: Sensex jumps over 300 points, Nifty above 15500 led by metals, FMCG ...
Stock Market Live Updates: Indian equity indices, Sensex and Nifty are ... Energy and pharma sectors also added to the gains, lifting the benchmark ...
Read more: Stock Market Live Updates: Sensex jumps over 300 points, Nifty above 15500 led by metals, FMCG ...
Read more: Stock Market Live Updates: Sensex jumps over 300 points, Nifty above 15500 led by metals, FMCG ...
Pharma Reviews: With PharmEasy acquiring MedLife, the e-pharmacy sector to see a paradigm shift
The MedTech sector broadly comprises three parts – e-pharmacy, diagnostics, and medical equipment. Further, the Indian Economic Survey of 2021 ...
Read more: With PharmEasy acquiring MedLife, the e-pharmacy sector to see a paradigm shift
Read more: With PharmEasy acquiring MedLife, the e-pharmacy sector to see a paradigm shift
Pharma Reviews: Nifty closes at record high, Sensex at 51937; rise 1%; energy, metal lead gains
Benchmark Indian equity indices closed 1% higher on Monday after a ... Drug firm Aurobindo Pharma on Monday reported a consolidated net profit of ...
Read more: Nifty closes at record high, Sensex at 51937; rise 1%; energy, metal lead gains
Read more: Nifty closes at record high, Sensex at 51937; rise 1%; energy, metal lead gains
Sunday, May 30, 2021
Pharma Reviews: Stock Market Live Updates: Sensex jumps 300 points, Nifty at new high; auto, IT stocks drag
Indian indices started the week on a flat note with gains in FMCG, pharma and metal sectors capped by losses in auto and banking indices. At 9:18 am ...
Read more: Stock Market Live Updates: Sensex jumps 300 points, Nifty at new high; auto, IT stocks drag
Read more: Stock Market Live Updates: Sensex jumps 300 points, Nifty at new high; auto, IT stocks drag
Pharma Reviews: Why is India lacking drugs to beat Covid and black fungus?
What is the role of governments and pharma industries in discovering corona drugs in India. What efforts have been made by the two so far to invent ...
Read more: Why is India lacking drugs to beat Covid and black fungus?
Read more: Why is India lacking drugs to beat Covid and black fungus?
Saturday, May 29, 2021
Pharma Reviews: Indian Immunologiclas to start drug substance production for Covaxin from June
To further increase the COVID-19 vaccine manufacturing capacity, Bharat Biotech had said it partnered with IIL to make the drug substance for Covaxin.
Read more: Indian Immunologiclas to start drug substance production for Covaxin from June
Read more: Indian Immunologiclas to start drug substance production for Covaxin from June
Pharma Reviews: Covid-19: Shortage of black fungus drug looming
On May 22, there were 8,848 cases across India according to the central ... Five new companies, Emcure Pharmaceuticals, Natco Pharma, Gufic ...
Read more: Covid-19: Shortage of black fungus drug looming
Read more: Covid-19: Shortage of black fungus drug looming
Pharma Reviews: India's pharma industry vital for world's vaccination programme
It is well placed to attract investments so that production can start in no time. India's pharmaceuticals and medical devices industry has the resilience and ...
Read more: India's pharma industry vital for world's vaccination programme
Read more: India's pharma industry vital for world's vaccination programme
Pharma Reviews: The Patent Crisis
This is due to the patents that in India, out of 3000 pharma companies with a strong network of over 10,500 manufacturing facilities, only two ...
Read more: The Patent Crisis
Read more: The Patent Crisis
Pharma Reviews: These two bright minds have made Zeno Health a force to reckon with in Pharma industry
Siddharth Gadia and Girish Agarwal, both IIT Bombay alumni, established the company in 2017. Zeno Health is India's fastest-growing pharmacy retail ...
Read more: These two bright minds have made Zeno Health a force to reckon with in Pharma industry
Read more: These two bright minds have made Zeno Health a force to reckon with in Pharma industry
Pharma Reviews: Gainers & Losers: 10 stocks that moved most on May 28
The pharma company's Q4 net profit was up 87.6 percent at Rs 161.3 crore versus Rs ... Sweden, the parent company of AstraZeneca Pharma India.
Read more: Gainers & Losers: 10 stocks that moved most on May 28
Read more: Gainers & Losers: 10 stocks that moved most on May 28
Friday, May 28, 2021
Pharma Reviews: Top 5 Most In-Demand Skills in the Post-Covid Times
Moreover, India is credited with being the highest provider of general drugs and medicines around the world and Indian pharma companies provide ...
Read more: Top 5 Most In-Demand Skills in the Post-Covid Times
Read more: Top 5 Most In-Demand Skills in the Post-Covid Times
Pharma Reviews: Live market updates
Zydus Cadila, an innovation-driven pharmaceutical company has ... humanitarian efforts across India for medical supplies during this pandemic.
Read more: Live market updates
Read more: Live market updates
US FDA News: Dash Xclusive Issues Voluntary Nationwide Recall of Imperia Elita Vitaccino Coffee Due to the Presence of Undeclared Sibutramine and Fluoxetine
Dash Xclusive is voluntarily recalling all lots of Imperia Elita Vitaccino Coffee to the consumer level. FDA analysis has found the product to contain undeclared sibutramine and fluoxetine.
Read more: Dash Xclusive Issues Voluntary Nationwide Recall of Imperia Elita Vitaccino Coffee Due to the Presence of Undeclared Sibutramine and Fluoxetine
Read more: Dash Xclusive Issues Voluntary Nationwide Recall of Imperia Elita Vitaccino Coffee Due to the Presence of Undeclared Sibutramine and Fluoxetine
US FDA News: FDA Seeks $6.5 Billion to Further Investments in Critical Public Health Infrastructure, Core Food Safety and Medical Product Safety Programs
FDA seeks $6.5 billion as part of President’s 2022 budget, a nearly 8% increase over FY2021 funding.
Read more: FDA Seeks $6.5 Billion to Further Investments in Critical Public Health Infrastructure, Core Food Safety and Medical Product Safety Programs
Read more: FDA Seeks $6.5 Billion to Further Investments in Critical Public Health Infrastructure, Core Food Safety and Medical Product Safety Programs
US FDA News: Step-Har Medical Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts
Bezel posts on the Alaris Infusion Pump Module 8100 are critical to pump function. Step-Har repair bezel posts may crack or separate.
Read more: Step-Har Medical Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts
Read more: Step-Har Medical Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts
US FDA News: FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy
The FDA approved the first targeted therapy for adult patients with non-small cell lung cancer whose tumors have a genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.
Read more: FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy
Read more: FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy
US FDA News: Lepu Medical Technology Recalls SARS-CoV-2 Antigen Rapid Test Kit and Leccurate SARS-CoV-2 Antibody Rapid Test Kit (Colloidal Gold Immunochromatography) due to Risk of False Results
The SARS-CoV-2 Antigen Rapid Test Kit and Leccurate SARS-CoV-2 Antibody Rapid Test Kit (Colloidal Gold Immunochromatography) have a likely risk of false results
Read more: Lepu Medical Technology Recalls SARS-CoV-2 Antigen Rapid Test Kit and Leccurate SARS-CoV-2 Antibody Rapid Test Kit (Colloidal Gold Immunochromatography) due to Risk of False Results
Read more: Lepu Medical Technology Recalls SARS-CoV-2 Antigen Rapid Test Kit and Leccurate SARS-CoV-2 Antibody Rapid Test Kit (Colloidal Gold Immunochromatography) due to Risk of False Results
US FDA News: Stop Using Lepu Medical Technology SARS-CoV-2 Antigen and Leccurate Antibody Tests: FDA Safety Communication
There is likely a high risk of false results using these tests. The tests are not FDA authorized, cleared, or approved.
Read more: Stop Using Lepu Medical Technology SARS-CoV-2 Antigen and Leccurate Antibody Tests: FDA Safety Communication
Read more: Stop Using Lepu Medical Technology SARS-CoV-2 Antigen and Leccurate Antibody Tests: FDA Safety Communication
Pharma Reviews: Sun Pharma joins biosimilars race, to target assets with patent expiries in 7-10 years
Sun Pharma, India's largest drug maker, said it will be joining the race to ... He added that Sun Pharma would develop biosimilars within the limits of ... Sun Pharma chief Shanghvi, known for his midas touch in the pharma industry, ...
Read more: Sun Pharma joins biosimilars race, to target assets with patent expiries in 7-10 years
Read more: Sun Pharma joins biosimilars race, to target assets with patent expiries in 7-10 years
Pharma Reviews: TLC-Strides to roll out CDSCO approved Liposomal Amphotericin B in India
Bengaluru: Strides Pharma Science Limited, a global pharmaceutical company, and TLC, a clinical‐stage specialty pharmaceutical company developing ...
Read more: TLC-Strides to roll out CDSCO approved Liposomal Amphotericin B in India
Read more: TLC-Strides to roll out CDSCO approved Liposomal Amphotericin B in India
Pharma Reviews: Market LIVE Updates: Nifty hits record high, Sensex near day's high; RIL top gainer
Reliance Industries, JSW Steel, Grasim, Tata Steel and Coal India were among major gainers on the Nifty, while losers included Sun Pharma, M&M, ...
Read more: Market LIVE Updates: Nifty hits record high, Sensex near day's high; RIL top gainer
Read more: Market LIVE Updates: Nifty hits record high, Sensex near day's high; RIL top gainer
Pharma Reviews: Market LIVE Update: Sensex rises over 250 pts; Nifty above 15.4k; metal gains
New India Assurance Co assigned corporate credit rating by Crisil ... The "Sun Pharma reported results below the market expectation for Q4FY21.
Read more: Market LIVE Update: Sensex rises over 250 pts; Nifty above 15.4k; metal gains
Read more: Market LIVE Update: Sensex rises over 250 pts; Nifty above 15.4k; metal gains
Thursday, May 27, 2021
Pharma Reviews: Sun Pharma net profit doubles in Q4
The company's consolidated net profit rose to Rs 894.15 crore during the quarter primarily due to a robust performance in the Indian market. Sun Pharma ...
Read more: Sun Pharma net profit doubles in Q4
Read more: Sun Pharma net profit doubles in Q4
Pharma Reviews: Markets likely to gain on global cues; M&M, Sun Pharma, Glenmark in focus
Mahindra & Mahindra, REC, Ipca Laboratories, Sundaram Finance, Max Healthcare, Glenmark Pharmaceuticals, Aditya Birla Fashion & Retail, Indian ...
Read more: Markets likely to gain on global cues; M&M, Sun Pharma, Glenmark in focus
Read more: Markets likely to gain on global cues; M&M, Sun Pharma, Glenmark in focus
Pharma Reviews: Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show
India's largest pharma firm, Mumbai head-quarterd Sun Pharmaceuticals, posted a 124 per cent year-on-year rise in net profit in the fourth quarter of ...
Read more: Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show
Read more: Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show
Pharma Reviews: Gainers & Losers: 10 stocks that moved most on May 24
Domestic brokerage firm Kotak Institutional Equities has downgraded the stock to reduce from buy as valuations are rich. It has a ... RDIF has tied up with six Indian drug makers to manufacture and supply the vaccine. Viswanath Pilla ...
Read more: Gainers & Losers: 10 stocks that moved most on May 24
Read more: Gainers & Losers: 10 stocks that moved most on May 24
US FDA News: Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities
Read more on the domestic supply of new respirators, including N95s and other FFRs, elastomeric respirators, powered air-purifying respirators (PAPRs)
Read more: Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities
Read more: Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities
Pharma Reviews: India to produce 259 cr Covid vax doses by year-end
Reddy said hospitals used to get one case of black fungus in six months and pharma companies had decreased the production of the drug. He pointed ...
Read more: India to produce 259 cr Covid vax doses by year-end
Read more: India to produce 259 cr Covid vax doses by year-end
Pharma Reviews: Market LIVE Update: Sensex up 164 pts; Nifty above 15.3k; pharma, realty gain
Benchmark Indian equity indices opened higher on Thursday. Asian stocks were steady early Thursday after gains in U.S. shares tied to the economic ...
Read more: Market LIVE Update: Sensex up 164 pts; Nifty above 15.3k; pharma, realty gain
Read more: Market LIVE Update: Sensex up 164 pts; Nifty above 15.3k; pharma, realty gain
Wednesday, May 26, 2021
Pharma Reviews: Markets may consolidate as Nifty nears record high; BPCL, Sun Pharma in focus
Major companies that will announce March quarter results today are Sun Pharma, Eicher Motors, Cadila Healthcare, Page Industries, UCO Bank, India ...
Read more: Markets may consolidate as Nifty nears record high; BPCL, Sun Pharma in focus
Read more: Markets may consolidate as Nifty nears record high; BPCL, Sun Pharma in focus
US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19
The FDA issued an emergency use authorization for the investigational monoclonal antibody therapy sotrovimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19
Pharma Reviews: UAE seeks investment from Indian pharma companies
The United Arab Emirates has sought Indian investment in the pharmaceutical sector and promised to support any such venture. "We have great ...
Read more: UAE seeks investment from Indian pharma companies
Read more: UAE seeks investment from Indian pharma companies
Pharma Reviews: Govt looking into securing part of J&J vaccines for Indian market: Sources
The sources privy to the discussions said another US pharma company, Moderna, does not have surplus jabs to share in 2021, and is expected to ...
Read more: Govt looking into securing part of J&J vaccines for Indian market: Sources
Read more: Govt looking into securing part of J&J vaccines for Indian market: Sources
Pharma Reviews: Indian health-tech market to grow to $50 billion by 2033
The health-tech market comprises of six segments -- telemedicine, e-pharmacy, fitness, wellness, healthcare IT, analytics, home healthcare and personal ...
Read more: Indian health-tech market to grow to $50 billion by 2033
Read more: Indian health-tech market to grow to $50 billion by 2033
Pharma Reviews: Zydus Cadila, Taiwan's TLC ink pact to market black fungus drug in India
The companies have announced the signing of an agreement to commercialise AmphoTLC (Amphotericin B Liposome for Injection 50mg) in India, ...
Read more: Zydus Cadila, Taiwan's TLC ink pact to market black fungus drug in India
Read more: Zydus Cadila, Taiwan's TLC ink pact to market black fungus drug in India
US FDA News: FDA, FTC Warn Five Companies Illegally Selling Dietary Supplements Claiming to Treat Infertility
FDA, FTC issues warning letters to five companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent infertility
Read more: FDA, FTC Warn Five Companies Illegally Selling Dietary Supplements Claiming to Treat Infertility
Read more: FDA, FTC Warn Five Companies Illegally Selling Dietary Supplements Claiming to Treat Infertility
US FDA News: Ocaliva (obeticholic acid) by Intercept Pharmaceuticals: Drug Safety Communication - Due to Risk of Serious Liver Injury, FDA Restricts Use of Ocaliva in Primary Biliary Cholangitis Patients with Advanced Cirrhosis
FDA is restricting the use of the liver disease medicine Ocaliva (obeticholic acid) in patients having primary biliary cholangitis with advanced cirrhosis of the liver because some patients with cirrhosis who took Ocaliva, especially those with evidence of advanced cirrhosis, developed liver failure
Read more: Ocaliva (obeticholic acid) by Intercept Pharmaceuticals: Drug Safety Communication - Due to Risk of Serious Liver Injury, FDA Restricts Use of Ocaliva in Primary Biliary Cholangitis Patients with Advanced Cirrhosis
Read more: Ocaliva (obeticholic acid) by Intercept Pharmaceuticals: Drug Safety Communication - Due to Risk of Serious Liver Injury, FDA Restricts Use of Ocaliva in Primary Biliary Cholangitis Patients with Advanced Cirrhosis
US FDA News: FDA In Brief: FDA Announces Draft Guidances to Help Increase Transparency, Assist Reporting and Timely Completion for Certain Medical Device Studies after FDA Approval or Clearance
Both guidances will assist stakeholders with post-approval study requirements and postmarket surveillance plans as well as the FDA policy of publishing data.
Read more: FDA In Brief: FDA Announces Draft Guidances to Help Increase Transparency, Assist Reporting and Timely Completion for Certain Medical Device Studies after FDA Approval or Clearance
Read more: FDA In Brief: FDA Announces Draft Guidances to Help Increase Transparency, Assist Reporting and Timely Completion for Certain Medical Device Studies after FDA Approval or Clearance
Pharma Reviews: PharmaState Academy to hold H2H Marketing discussion with Prof. Philip Kotler, co-authors
The event has been scheduled to start at 07:00 PM IST. Other Eminent speakers from the Indian pharma industry including Pranav Kumar, Prashant ...
Read more: PharmaState Academy to hold H2H Marketing discussion with Prof. Philip Kotler, co-authors
Read more: PharmaState Academy to hold H2H Marketing discussion with Prof. Philip Kotler, co-authors
Pharma Reviews: Building agile and scalable pharma cold chain
Indian pharma cold chain players are extremely positive about the growth of their industry due to innovations in pharma manufacturing and the degree ...
Read more: Building agile and scalable pharma cold chain
Read more: Building agile and scalable pharma cold chain
Pharma Reviews: How Covaxin became a victim of vaccine triumphalism
How had the Indian drug regulator, the Drug Controller General of India (DCGI), given a green signal to the vaccine, if its manufacturing process had ...
Read more: How Covaxin became a victim of vaccine triumphalism
Read more: How Covaxin became a victim of vaccine triumphalism
Pharma Reviews: Industry 4.0 technologies critical for India's pharma supply chains to combat COVID-19
Rockwell Automation recently organised an online forum titled 'How Industry 4.0 can Strengthen India's Pharma Sector' where the company's ...
Read more: Industry 4.0 technologies critical for India's pharma supply chains to combat COVID-19
Read more: Industry 4.0 technologies critical for India's pharma supply chains to combat COVID-19
Tuesday, May 25, 2021
Pharma Reviews: Trouble Mounts For Baba Ramdev As Medical Fraternity Demands Arrest For Allopathy Attack
Indian Medical Association (IMA) Uttararanchal State Branch writes to ... asked for their solution and treatment in the allopathy and pharma industry.
Read more: Trouble Mounts For Baba Ramdev As Medical Fraternity Demands Arrest For Allopathy Attack
Read more: Trouble Mounts For Baba Ramdev As Medical Fraternity Demands Arrest For Allopathy Attack
US FDA News: Medically Minded Hand Sanitizer– Nationwide Recall Expansion Due to The Presence of Undeclared Methanol
This recall has been initiated due to the presence of undeclared Methanol. Use of or consumption of this product can result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma & or permanent damage to the nervous system or death. Although all persons using these produc
Read more: Medically Minded Hand Sanitizer– Nationwide Recall Expansion Due to The Presence of Undeclared Methanol
Read more: Medically Minded Hand Sanitizer– Nationwide Recall Expansion Due to The Presence of Undeclared Methanol
Pharma Reviews: PharmEasy acquires Medlife, becomes India's largest e-pharma company
PharmEasy acquires Medlife, becomes India's largest e-pharma company. Samreen Ahmad | Bengaluru | Last Updated at May 25 2021 19:21 IST.
Read more: PharmEasy acquires Medlife, becomes India's largest e-pharma company
Read more: PharmEasy acquires Medlife, becomes India's largest e-pharma company
Pharma Reviews: Digital Messaging: Approach for Pharmaceutical Brand Marketers
From my experience of talking to friends in the industry, Indian pharma had a slightly different problem. In most of the cases what mid-level managers ...
Read more: Digital Messaging: Approach for Pharmaceutical Brand Marketers
Read more: Digital Messaging: Approach for Pharmaceutical Brand Marketers
Pharma Reviews: At-home Covid testing kits to be available in 3-4 days: ICMR
... in the market in the next three to four days, the Indian Council of Medical ... One company has approval for home testing kits, three more are in the ...
Read more: At-home Covid testing kits to be available in 3-4 days: ICMR
Read more: At-home Covid testing kits to be available in 3-4 days: ICMR
Monday, May 24, 2021
Pharma Reviews: Baba Ramdev fires 25 questions at IMA, asks if they have permanent treatments for diabetes ...
In an open letter addressed to the Indian Medical Association and pharma companies, he asked for permanent solutions offered by allopathy to treat ...
Read more: Baba Ramdev fires 25 questions at IMA, asks if they have permanent treatments for diabetes ...
Read more: Baba Ramdev fires 25 questions at IMA, asks if they have permanent treatments for diabetes ...
Pharma Reviews: In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us
Pharmaceutical companies often outsource trial-related operations to contract research organisations (CROs). Parexel is one of the world's largest ...
Read more: In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us
Read more: In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us
Pharma Reviews: Baba Ramdev puts 25 questions before IMA after allopathy foot-in-mouth episode
... of allopathy medicines, yoga guru Ramdev on Monday asked the Indian ... "Does the pharma industry have permanent treatment for thyroid, arthritis, ...
Read more: Baba Ramdev puts 25 questions before IMA after allopathy foot-in-mouth episode
Read more: Baba Ramdev puts 25 questions before IMA after allopathy foot-in-mouth episode
Pharma Reviews: Smarting under statement withdrawal, Ramdev poses 25 questions to IMA
... yoga guru Baba Ramdev on Monday asked the Indian Medical Association ... "Does the pharma industry have permanent treatment for thyroid, arthritis, ... Ramdev went on to ask if allopathy had medicines for fatty liver and liver ...
Read more: Smarting under statement withdrawal, Ramdev poses 25 questions to IMA
Read more: Smarting under statement withdrawal, Ramdev poses 25 questions to IMA
US FDA News: Medical Action Industries, Inc. 306 Recalls Medical Convenience Kits for Risk of Fungal (Aspergillus Penicillioides) Contamination
Medical convenience kits group devices together for medical providers. The MAI kits contain ChloraPrep 3mL and is under recall for fungal contamination risk.
Read more: Medical Action Industries, Inc. 306 Recalls Medical Convenience Kits for Risk of Fungal (Aspergillus Penicillioides) Contamination
Read more: Medical Action Industries, Inc. 306 Recalls Medical Convenience Kits for Risk of Fungal (Aspergillus Penicillioides) Contamination
Pharma Reviews: Smarting under statement withdrawal, Ramdev poses 25 questions to IMA
... of allopathy medicines, yoga guru Ramdev on Monday asked the Indian ... “Does the pharma industry have permanent treatment for thyroid, arthritis, ...
Read more: Smarting under statement withdrawal, Ramdev poses 25 questions to IMA
Read more: Smarting under statement withdrawal, Ramdev poses 25 questions to IMA
Pharma Reviews: Cybercrime thrives during pandemic: Verizon
Two Indian pharma companies were attacked. We also saw internet of things (IoT)-enabled devices being targeted, be it used for remote medicine or ...
Read more: Cybercrime thrives during pandemic: Verizon
Read more: Cybercrime thrives during pandemic: Verizon
Pharma Reviews: Market LIVE Updates: Sensex up 133 pts, Nifty above 15k; FMCG, telecom drag
The local chapter of the Indian Chamber of Commerce and Industry on ... Drug firm Eli Lilly has signed a voluntary licensing agreement with Natco ...
Read more: Market LIVE Updates: Sensex up 133 pts, Nifty above 15k; FMCG, telecom drag
Read more: Market LIVE Updates: Sensex up 133 pts, Nifty above 15k; FMCG, telecom drag
Sunday, May 23, 2021
Pharma Reviews: India's Biological E. to produce Johnson & Johnson's Covid-19 vaccine
J&J confirmed to Reuters it was working with Biological E. on manufacturing its ... The drug has been developed with Baylor College of Medicine in Houston and ... Reuters reported on Tuesday that India was unlikely to resume major ...
Read more: India's Biological E. to produce Johnson & Johnson's Covid-19 vaccine
Read more: India's Biological E. to produce Johnson & Johnson's Covid-19 vaccine
Pharma Reviews: Shilpa Medicare arm inks pact with Dr Reddy's to manufacture Sputnik V vaccine
Drug firm Shilpa Medicare on Monday said its arm has entered into a ... in India on May 1 and received regulatory clearance from the Central Drugs ...
Read more: Shilpa Medicare arm inks pact with Dr Reddy's to manufacture Sputnik V vaccine
Read more: Shilpa Medicare arm inks pact with Dr Reddy's to manufacture Sputnik V vaccine
Pharma Reviews: Stocks to watch: SBI, JSW Steel, Sun Pharma, Hindalco, Reliance, Dr Lal PathLabs, Shriram Life ...
Steel companies' stocks may see an impact of a letter written by industry body Indian Pipe Manufacturers' Association (IPMA) to the government.
Read more: Stocks to watch: SBI, JSW Steel, Sun Pharma, Hindalco, Reliance, Dr Lal PathLabs, Shriram Life ...
Read more: Stocks to watch: SBI, JSW Steel, Sun Pharma, Hindalco, Reliance, Dr Lal PathLabs, Shriram Life ...
Pharma Reviews: Milind Deora credits Congress party for hard work of industrialists and private individuals usually ...
The Congress leader listed 5 Indian pharmaceutical companies in the private ... Bharat Biotech, the Indian biotechnology company headquartered in ...
Read more: Milind Deora credits Congress party for hard work of industrialists and private individuals usually ...
Read more: Milind Deora credits Congress party for hard work of industrialists and private individuals usually ...
Saturday, May 22, 2021
Pharma Reviews: Morepen EGM approves Rs.433 cr incoming investment from Corinth and promoters
It is a testing time for life sciences and pharmaceutical companies, in these ... Speaking about the opportunities that the Indian market presents, Mr.
Read more: Morepen EGM approves Rs.433 cr incoming investment from Corinth and promoters
Read more: Morepen EGM approves Rs.433 cr incoming investment from Corinth and promoters
Pharma Reviews: Indian Immunologicals likely to start Covaxin antigen production in June: Report
The Medical Dialogues team had earlier reported that in order to expand the Covaxin manufacturing, Bharat Biotech had partnered with Indian ...
Read more: Indian Immunologicals likely to start Covaxin antigen production in June: Report
Read more: Indian Immunologicals likely to start Covaxin antigen production in June: Report
Friday, May 21, 2021
Pharma Reviews: Morepen gets shareholder nod to raise Rs 433 cr
“The investment into Morepen follows from our increased focus on emerging markets, and in particular the health and pharmaceutical industry. India is ...
Read more: Morepen gets shareholder nod to raise Rs 433 cr
Read more: Morepen gets shareholder nod to raise Rs 433 cr
Pharma Reviews: India: World's Biggest Producer Fails to Vaccinate its People
This is how the Indian public sector and other indigenous manufacturers developed the world's biggest generic drug and vaccine manufacturing capacity ...
Read more: India: World's Biggest Producer Fails to Vaccinate its People
Read more: India: World's Biggest Producer Fails to Vaccinate its People
US FDA News: FDA Announces Seizure of Adulterated Dietary Supplements Containing Kratom
FDA announced that U.S. Marshals, at the agency’s request, seized more than 207,000 units of dietary supplements and bulk dietary ingredients that are or contain kratom, including over 34,000 kilograms of bulk kratom.
Read more: FDA Announces Seizure of Adulterated Dietary Supplements Containing Kratom
Read more: FDA Announces Seizure of Adulterated Dietary Supplements Containing Kratom
US FDA News: Coronavirus (COVID-19) Update: May 21, 2021
The FDA updated the definition of high risk for COVID-19 to include additional medical conditions and factors associated with increased risk for progression to severe disease.
Read more: Coronavirus (COVID-19) Update: May 21, 2021
Read more: Coronavirus (COVID-19) Update: May 21, 2021
US FDA News: Boston Scientific Corporation Recalls VICI VENOUS STENT System and VICI RDS VENOUS STENT System for Potential of Stent Migration
The VICI SDS and RDS VENOUS STENT Systems treat narrowed or blocked venous veins. There is a recall because the stents may migrate after implantation.
Read more: Boston Scientific Corporation Recalls VICI VENOUS STENT System and VICI RDS VENOUS STENT System for Potential of Stent Migration
Read more: Boston Scientific Corporation Recalls VICI VENOUS STENT System and VICI RDS VENOUS STENT System for Potential of Stent Migration
Pharma Reviews: Prices of Sputnik V Covid-19 vaccine may drop after local manufacturing begins: Dr Reddy's
The company spokesperson told ANI, "The current MRP of Rs. 948 + 5 ... Around 60 to 70 percent of the vaccines will be made in India and most of it will be ... Panacea Biotec, Gland Pharma, Stelis Biopharma and Shilpa Medicare.
Read more: Prices of Sputnik V Covid-19 vaccine may drop after local manufacturing begins: Dr Reddy's
Read more: Prices of Sputnik V Covid-19 vaccine may drop after local manufacturing begins: Dr Reddy's
US FDA News: FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer
The FDA approved the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations called EGFR exon 20 insertion mutations.
Read more: FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer
Read more: FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer
Pharma Reviews: PLI scheme: The desired boost for the growth of the nutraceutical sector
PLI scheme for the nutraceutical industry if carefully drafted with an ... manufacturing beyond just supplying the herbs and medicinal plants to the world. ... PLI scheme can boost domestic manufacturing and augment India's exports ...
Read more: PLI scheme: The desired boost for the growth of the nutraceutical sector
Read more: PLI scheme: The desired boost for the growth of the nutraceutical sector
US FDA News: Mammography Problems at Advanced Women Imaging in Guttenberg, NJ
The U.S. Food and Drug Administration (FDA) is alerting patients who had mammograms at Advanced Women Imaging, located in Guttenberg, NJ, on or after March 11, 2020, about possible problems with the quality of their mammograms.
Read more: Mammography Problems at Advanced Women Imaging in Guttenberg, NJ
Read more: Mammography Problems at Advanced Women Imaging in Guttenberg, NJ
Pharma Reviews: Morepen gets shareholder nod to raise Rs 433 crore
"The investment into Morepen follows from our increased focus on emerging markets, and in particular the health and pharmaceutical industry. India is ...
Read more: Morepen gets shareholder nod to raise Rs 433 crore
Read more: Morepen gets shareholder nod to raise Rs 433 crore
Pharma Reviews: Stock Market Live Updates: Sensex near day's high, Nifty above 15000 led by banks, financials
Stock Market Live Updates: Indian equity indices, Sensex and Nifty are ... Looking at cost efficiency projects; cosmetics and pharma growth drivers: ...
Read more: Stock Market Live Updates: Sensex near day's high, Nifty above 15000 led by banks, financials
Read more: Stock Market Live Updates: Sensex near day's high, Nifty above 15000 led by banks, financials
Thursday, May 20, 2021
Pharma Reviews: Sun Pharma appoints Pawan Goenka and Rama Bijapurkar as Additional Independent Directors
The appointments come into effect from May 21, 2021, to hold office up to the ensuing 29th Annual General Meeting of the company. May 21, 2021 ...
Read more: Sun Pharma appoints Pawan Goenka and Rama Bijapurkar as Additional Independent Directors
Read more: Sun Pharma appoints Pawan Goenka and Rama Bijapurkar as Additional Independent Directors
Pharma Reviews: Five pharmaceutical companies get approval to make black fungus drug
The Drugs Controller General of India (DCGI) has cleared applications from five pharmaceutical companies to manufacture anti-fungal drug ...
Read more: Five pharmaceutical companies get approval to make black fungus drug
Read more: Five pharmaceutical companies get approval to make black fungus drug
Pharma Reviews: Health is wealth: A low-cost option to boost your MF portfolio
Hospitals are the bedrock of medical infrastructure. The hospital industry in India, that accounts for 80 percent of the total healthcare sector and is ...
Read more: Health is wealth: A low-cost option to boost your MF portfolio
Read more: Health is wealth: A low-cost option to boost your MF portfolio
Pharma Reviews: Buzzing Stocks: SBI, HPCL, Havells India and others that will be in focus today
... Hindalco Industries, JSW Steel, Shree Cement, Godrej Industries, South Indian Bank, Aarti Surfactants, AF Enterprises, Anmol India, Anuh Pharma, ...
Read more: Buzzing Stocks: SBI, HPCL, Havells India and others that will be in focus today
Read more: Buzzing Stocks: SBI, HPCL, Havells India and others that will be in focus today
Pharma Reviews: Key drugs, steroids in short supply; input costs surge
Rakesh Bamzai, president, India, Emerging Asia & Access Markets at Viatris, said his company and Gilead are closely working with the government to ...
Read more: Key drugs, steroids in short supply; input costs surge
Read more: Key drugs, steroids in short supply; input costs surge
US FDA News: Stop Using Certain Syringes and Needles with Needle Safety Devices Manufactured by HAIOU – Letter to Health Care Providers
Certain syringes and needles with needle safety devices manufactured by HAIOU may cause needles to detach in patients’ arms after injection or needle failure.
Read more: Stop Using Certain Syringes and Needles with Needle Safety Devices Manufactured by HAIOU – Letter to Health Care Providers
Read more: Stop Using Certain Syringes and Needles with Needle Safety Devices Manufactured by HAIOU – Letter to Health Care Providers
Pharma Reviews: Cipla will maintain its EBITDA at 22% in FY22, says Kedar Upadhye
"To put a brake on the way the number of COVID cases is surging in India, it is our and pharma industry's responsibility to launch all the drugs in India ...
Read more: Cipla will maintain its EBITDA at 22% in FY22, says Kedar Upadhye
Read more: Cipla will maintain its EBITDA at 22% in FY22, says Kedar Upadhye
US FDA News: FDA In Brief: FDA Solicits Public Feedback on Discussion Paper as Part of its Ongoing Commitment to Patient Safety
FDA publishes a discussion paper to solicit feedback on the scope of device-related materials information and the ways it could be communicated to the intended users.
Read more: FDA In Brief: FDA Solicits Public Feedback on Discussion Paper as Part of its Ongoing Commitment to Patient Safety
Read more: FDA In Brief: FDA Solicits Public Feedback on Discussion Paper as Part of its Ongoing Commitment to Patient Safety
US FDA News: FDA In Brief: FDA Alerts Patients and Health Care Providers About Possible Problems with Mammograms Performed at Capitol Radiology LLC
FDA issues safety communication at Capitol Radiology LLC, also known as Laurel Radiology Services, in Laurel, Maryland.
Read more: FDA In Brief: FDA Alerts Patients and Health Care Providers About Possible Problems with Mammograms Performed at Capitol Radiology LLC
Read more: FDA In Brief: FDA Alerts Patients and Health Care Providers About Possible Problems with Mammograms Performed at Capitol Radiology LLC
US FDA News: Mammography Problems at Capitol Radiology, LLC, doing business as Laurel Radiology Services in Laurel, Maryland: FDA Safety Communication
The FDA is alerting patients who had mammograms at Capitol Radiology, LLC in Laurel, Maryland, on or after June 26, 2018, about possible problems with the quality of their mammograms.
Read more: Mammography Problems at Capitol Radiology, LLC, doing business as Laurel Radiology Services in Laurel, Maryland: FDA Safety Communication
Read more: Mammography Problems at Capitol Radiology, LLC, doing business as Laurel Radiology Services in Laurel, Maryland: FDA Safety Communication
Pharma Reviews: Covid: Amid shortage of drug to treat 'black fungus', Centre says 6 lakh vials will be imported soon
The Centre on Tuesday said that Indian companies will import six lakh vials of Amphotericin B, the drug used to treat “black fungus” infections, and that ...
Read more: Covid: Amid shortage of drug to treat 'black fungus', Centre says 6 lakh vials will be imported soon
Read more: Covid: Amid shortage of drug to treat 'black fungus', Centre says 6 lakh vials will be imported soon
Pharma Reviews: Grapes Digital bags the PR mandate for Mankind Pharma
MUMBAI: Mankind Pharma, the fourth largest pharmaceutical manufacturing company headquartered in India has appointed Grapes Digital to handle ...
Read more: Grapes Digital bags the PR mandate for Mankind Pharma
Read more: Grapes Digital bags the PR mandate for Mankind Pharma
Pharma Reviews: Counterfeit drugs, medical devices during Covid-19: Collective effort required to tackle menace ...
What is the Status in India? Is counterfeiting affecting only the pharmaceutical industry? What are the latest trends? Substandard, spurious, falsely ...
Read more: Counterfeit drugs, medical devices during Covid-19: Collective effort required to tackle menace ...
Read more: Counterfeit drugs, medical devices during Covid-19: Collective effort required to tackle menace ...
Wednesday, May 19, 2021
Pharma Reviews: Drugmakers cry 'monopoly' as Modi govt picks 1 firm each to make over 20 key raw materials
PLI scheme is supposed to end India's dependence on Chinese imports, but drug lobby says firms could end up dependent on one company for a ...
Read more: Drugmakers cry 'monopoly' as Modi govt picks 1 firm each to make over 20 key raw materials
Read more: Drugmakers cry 'monopoly' as Modi govt picks 1 firm each to make over 20 key raw materials
Pharma Reviews: Even if brands are not relevant to the Covid-19 situation, they've to show compassion and empathy ...
How pharmaceutical giant Mankind Pharma has pivoted its marketing strategy. In India, brands are trying to figure out the right way to communicate ...
Read more: Even if brands are not relevant to the Covid-19 situation, they've to show compassion and empathy ...
Read more: Even if brands are not relevant to the Covid-19 situation, they've to show compassion and empathy ...
US FDA News: FDA In Brief: FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution, Making Vaccine More Widely Available
FDA authorized undiluted, thawed Pfizer-BioNTech COVID-19 Vaccine vials to be stored in the refrigerator at 2°C to 8°C (35°F to 46°F) for up to 1 month.
Read more: FDA In Brief: FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution, Making Vaccine More Widely Available
Read more: FDA In Brief: FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution, Making Vaccine More Widely Available
US FDA News: FDA In Brief: FDA Issues Draft Guidance on Early Clinical Studies for Certain Medical Devices to Improve Glycemic Control for Type 2 Diabetes
FDA issued a draft guidance with recommendations for feasibility and early feasibility clinical studies for devices intended to improve glycemic control in patients with Type 2 diabetes.
Read more: FDA In Brief: FDA Issues Draft Guidance on Early Clinical Studies for Certain Medical Devices to Improve Glycemic Control for Type 2 Diabetes
Read more: FDA In Brief: FDA Issues Draft Guidance on Early Clinical Studies for Certain Medical Devices to Improve Glycemic Control for Type 2 Diabetes
Pharma Reviews: Cipla will maintain its EBITDA at 22% in FY22: Kedar Upadhye
Q: You have recently signed a deal with Eli Lilly for the drug Baricitinib. ... it is our and pharma industry's responsibility to launch all the drugs in India ...
Read more: Cipla will maintain its EBITDA at 22% in FY22: Kedar Upadhye
Read more: Cipla will maintain its EBITDA at 22% in FY22: Kedar Upadhye
US FDA News: FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination
FDA issued a safety communication to advise against using SARS-CoV-2 antibody test results to evaluate immunity after COVID-19 vaccination.
Read more: FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination
Read more: FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination
US FDA News: Dibar Nutricional S. de R.L. De C.V. Issues Voluntary Nationwide Expanded Recall of Dibar Labs Hand Sanitizer Due to the Presence of Methanol (Wood Alcohol)
Morelia, Michoacán, Mexico, Dibar Nutricional S. de R.L. De C.V. (“Dibar”) is voluntarily recalling all Dibar Labs Hand Sanitizer packaged in 8oz and 16 oz bottles, respectively, to the consumer level (see Label 1 below). Dibar is also voluntarily recalling ProtectoRx Hand Sanitizer packaged in 2oz
Read more: Dibar Nutricional S. de R.L. De C.V. Issues Voluntary Nationwide Expanded Recall of Dibar Labs Hand Sanitizer Due to the Presence of Methanol (Wood Alcohol)
Read more: Dibar Nutricional S. de R.L. De C.V. Issues Voluntary Nationwide Expanded Recall of Dibar Labs Hand Sanitizer Due to the Presence of Methanol (Wood Alcohol)
US FDA News: Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication
FDA reminds the public and health care providers that results from currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity from COVID-19 at any time, and especially after the person received a COVID-19 vaccination.
Read more: Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication
Read more: Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication
Pharma Reviews: Pharma firms scramble to boost production of antifungal jab Amphotericin B as Black Fungus cases ...
Industry sources told Moneycontrol that it would take at least 15-30 days for new production to hit the market, as the drug is complex to manufacture and ...
Read more: Pharma firms scramble to boost production of antifungal jab Amphotericin B as Black Fungus cases ...
Read more: Pharma firms scramble to boost production of antifungal jab Amphotericin B as Black Fungus cases ...
Tuesday, May 18, 2021
Pharma Reviews: Prepare for third wave, keep stocks of key Covid drugs ready, Modi govt tells pharma firms
In a meeting held Tuesday, the Department of Pharmaceuticals (DoP) — the apex regulator for drug makers in India under the Ministry of Chemicals and ...
Read more: Prepare for third wave, keep stocks of key Covid drugs ready, Modi govt tells pharma firms
Read more: Prepare for third wave, keep stocks of key Covid drugs ready, Modi govt tells pharma firms
US FDA News: FDA In Brief: Science Forum Highlights Regulatory Science Advancements in Protecting and Promoting Public Health
The Science Forum is a unique opportunity for stakeholders to engage with and learn directly from FDA experts about a variety of cutting-edge research topics.
Read more: FDA In Brief: Science Forum Highlights Regulatory Science Advancements in Protecting and Promoting Public Health
Read more: FDA In Brief: Science Forum Highlights Regulatory Science Advancements in Protecting and Promoting Public Health
Pharma Reviews: What Role Can AI Play In Drug Supply Chain Management?
“AI application in the life science and pharmaceutical industry is gaining considerable momentum in India, especially in improving clinical trials, drug ...
Read more: What Role Can AI Play In Drug Supply Chain Management?
Read more: What Role Can AI Play In Drug Supply Chain Management?
Monday, May 17, 2021
Pharma Reviews: Market LIVE: Sensex tops 50k, up 500 points; Nifty above 15000; banks soar
Indian indices opened higher tracking other Asian markets and amid a steady ... With more Pharma companies tying up for vaccine manufacturing, ...
Read more: Market LIVE: Sensex tops 50k, up 500 points; Nifty above 15000; banks soar
Read more: Market LIVE: Sensex tops 50k, up 500 points; Nifty above 15000; banks soar
Pharma Reviews: Pharma industry will be given priority to come back into operation post Taukate: Goyal
The Minister said this on Sunday while interacting with the industry on preparedness for cyclone Taukate. According to Indian Meteorological ...
Read more: Pharma industry will be given priority to come back into operation post Taukate: Goyal
Read more: Pharma industry will be given priority to come back into operation post Taukate: Goyal
US FDA News: Recall Expansion of Durisan Non-Alcohol Hand Sanitizer
Sanit Technologies LLC d/b/a Durisan is updating its previously announced voluntary recall of Durisan Non Alcohol Antimicrobial Hand Sanitizer products that became contaminated with a common municipal water supply borne bacteria, Burkholderia contaminans. Use of a hand sanitizer contaminated with Bu
Read more: Recall Expansion of Durisan Non-Alcohol Hand Sanitizer
Read more: Recall Expansion of Durisan Non-Alcohol Hand Sanitizer
Pharma Reviews: 'Pharma industry wants slew of sops to shore up production'
Is India's pharma industry in a position to cope with the growing demand for the medicines and drugs required to provide treatment to the corona ...
Read more: 'Pharma industry wants slew of sops to shore up production'
Read more: 'Pharma industry wants slew of sops to shore up production'
US FDA News: FDA In Brief: FDA Provides Guidance on Master Protocols for Evaluating Prevention, Treatment Options for COVID-19
The FDA issued a final guidance that describes the agency’s current recommendations to sponsors of master protocols evaluating drugs for the treatment or prevention of COVID-19.
Read more: FDA In Brief: FDA Provides Guidance on Master Protocols for Evaluating Prevention, Treatment Options for COVID-19
Read more: FDA In Brief: FDA Provides Guidance on Master Protocols for Evaluating Prevention, Treatment Options for COVID-19
Pharma Reviews: People over profit: Why we must fight for patent waivers on Covid vaccines and drugs
Despite a great deal of lobbying against it and a lot of whining from Big Pharma, this legal regime led to the burgeoning of India's pharma industry, driven ...
Read more: People over profit: Why we must fight for patent waivers on Covid vaccines and drugs
Read more: People over profit: Why we must fight for patent waivers on Covid vaccines and drugs
Pharma Reviews: Analytics India Industry Study 2021
Pharma & Healthcare stood fourth with an 8.0% contribution to the analytics market. Many firms within the sector ramped up their hiring to build ...
Read more: Analytics India Industry Study 2021
Read more: Analytics India Industry Study 2021
Sunday, May 16, 2021
Pharma Reviews: Coronavirus India News Live Updates: India registers 2.81 lakh fresh COVID-19 cases, 4106 deaths
According to the Indian Council of Medical Research, 31,64,23,658 ... Sun Pharmaceutical Industries, Dr. Reddy's , MSN Laboratories and Torrent ...
Read more: Coronavirus India News Live Updates: India registers 2.81 lakh fresh COVID-19 cases, 4106 deaths
Read more: Coronavirus India News Live Updates: India registers 2.81 lakh fresh COVID-19 cases, 4106 deaths
Pharma Reviews: How Covid spurred a turnaround for India's e-pharma industry
Mumbai: According to a 2019 EY report, the Indian e-pharma sector was poised to touch $2.7 billion by 2023 from $360 million. The report cited an ...
Read more: How Covid spurred a turnaround for India's e-pharma industry
Read more: How Covid spurred a turnaround for India's e-pharma industry
Pharma Reviews: Tauktae Cyclone Live Tracking: 6 dead; Gujarat braces for impact
According to the India Meteorological Department (IMD), Tauktae which has taken ... or products in the supply chain of the pharma industry will be given priority to ... Paschim Gujarat Vij Company Ltd has fully prepared itself to restore ...
Read more: Tauktae Cyclone Live Tracking: 6 dead; Gujarat braces for impact
Read more: Tauktae Cyclone Live Tracking: 6 dead; Gujarat braces for impact
Pharma Reviews: PEs set to make a $3-4 billion bet on intermediate pharma companies
Global private equity (PE) investors are in a rush to bet on Indian firms that are in the thriving business of manufacturing active pharmaceutical ...
Read more: PEs set to make a $3-4 billion bet on intermediate pharma companies
Read more: PEs set to make a $3-4 billion bet on intermediate pharma companies
Pharma Reviews: Pharma industry to be given priority to come back to operation post Taukate: Goyal
Minister of State for Ports, Shipping and Waterways Mansukh Mandaviya also attended the meeting. Besides, senior officials of Indian Meteorological ...
Read more: Pharma industry to be given priority to come back to operation post Taukate: Goyal
Read more: Pharma industry to be given priority to come back to operation post Taukate: Goyal
Saturday, May 15, 2021
Pharma Reviews: 10 Best Pharma Company Stocks To Invest Now In India-2021
The Indian pharmaceutical industry is expected to be worth 33.18 billion dollars by 2023, and it will rank ninth in the world. The P/E ratio aids investors in ...
Read more: 10 Best Pharma Company Stocks To Invest Now In India-2021
Read more: 10 Best Pharma Company Stocks To Invest Now In India-2021
Pharma Reviews: Coronavirus LIVE: India's active caseload at 15% of total infection count
According to total sales audit data from world's largest pharmaceutical market research firm IMS Health, the Indian Pharma Market (IPM) grew 59 per ...
Read more: Coronavirus LIVE: India's active caseload at 15% of total infection count
Read more: Coronavirus LIVE: India's active caseload at 15% of total infection count
Friday, May 14, 2021
Pharma Reviews: Pharmaceutical market reports strong growth in April: Ind-Ra
Mumbai: India Ratings and Research (Ind-Ra) has said that the 51.5 percent year-on-year growth in India's pharmaceutical market during April was ...
Read more: Pharmaceutical market reports strong growth in April: Ind-Ra
Read more: Pharmaceutical market reports strong growth in April: Ind-Ra
Pharma Reviews: Covid-19 second wave drives Indian pharma market growth in April
Glenmark's Favipiravir, marketed as 'Fabiflu' | From a presentation submitted by Glenmark to the BSE India exchange. The pharma market in India has ...
Read more: Covid-19 second wave drives Indian pharma market growth in April
Read more: Covid-19 second wave drives Indian pharma market growth in April
Pharma Reviews: Congress Claims Credit For Vaccine Production Capability Ahead Of Upswing In Availability
Then, we had the FERA in 1973 which diluted the equity stakeholdings of multinational companies and allowed Indian pharmaceutical companies to ...
Read more: Congress Claims Credit For Vaccine Production Capability Ahead Of Upswing In Availability
Read more: Congress Claims Credit For Vaccine Production Capability Ahead Of Upswing In Availability
Pharma Reviews: Stock Market Live Updates: Sensex, Nifty trade lower dragged by metals; Dr Reddy's launches ...
Stock Market Live Updates: Indian indices were trading lower on Friday ... Alembic Pharmaceuticals | The company has received final approval from ...
Read more: Stock Market Live Updates: Sensex, Nifty trade lower dragged by metals; Dr Reddy's launches ...
Read more: Stock Market Live Updates: Sensex, Nifty trade lower dragged by metals; Dr Reddy's launches ...
Pharma Reviews: Dr Reddy's inks licensing pact with Eli Lilly for Covid-19 treatment drug
This partnership comes at a critical juncture in the fight against the pandemic in India, and adds to the company's existing range of Covid-19 ...
Read more: Dr Reddy's inks licensing pact with Eli Lilly for Covid-19 treatment drug
Read more: Dr Reddy's inks licensing pact with Eli Lilly for Covid-19 treatment drug
Thursday, May 13, 2021
Pharma Reviews: Indian Pharma sees robust growth of 51.5 percent in April sales: AIOCD-AWACS Report
New Delhi: The performance of the Indian Pharmaceutical Market (IPM) in April has portrayed a positive outlook for the Indian pharmaceutical industry ...
Read more: Indian Pharma sees robust growth of 51.5 percent in April sales: AIOCD-AWACS Report
Read more: Indian Pharma sees robust growth of 51.5 percent in April sales: AIOCD-AWACS Report
Pharma Reviews: Stock Market Live Updates: SGX Nifty indicates a negative start for Indian indices; UPL, Hindalco in ...
The pharma industry has reached out to the government on concerns over the rising input costs for drugs, according to people in the know.
Read more: Stock Market Live Updates: SGX Nifty indicates a negative start for Indian indices; UPL, Hindalco in ...
Read more: Stock Market Live Updates: SGX Nifty indicates a negative start for Indian indices; UPL, Hindalco in ...
Pharma Reviews: Big relief for import-dependent Indian pharma as Sichuan Airlines resumes cargo services
In a major relief to the import-dependent Indian pharmaceutical industry, Chinese state-owned Sichuan Airlines has resumed its cargo services to ...
Read more: Big relief for import-dependent Indian pharma as Sichuan Airlines resumes cargo services
Read more: Big relief for import-dependent Indian pharma as Sichuan Airlines resumes cargo services
US FDA News: FDA In Brief: FDA Releases Investigation Report Following 2020 Salmonella Outbreak Linked to Red Onions
Today, the FDA released a 2020 Salmonella Outbreak Report that includes an overview of our traceback, on-site investigation, and various factors that potentially contributed to the contamination of red onions with Salmonella.
Read more: FDA In Brief: FDA Releases Investigation Report Following 2020 Salmonella Outbreak Linked to Red Onions
Read more: FDA In Brief: FDA Releases Investigation Report Following 2020 Salmonella Outbreak Linked to Red Onions
US FDA News: FDA In Brief: FDA Continues to Monitor the Effects of Magnets in Consumer Electronics on Implanted Medical Devices
FDA is advising the public that electronic devices, such as certain cell phones and smart watches, have high field strength magnets capable of placing medical devices in their “magnet mode.” These magnets can affect normal operations of the medical device until the magnetic field is moved.
Read more: FDA In Brief: FDA Continues to Monitor the Effects of Magnets in Consumer Electronics on Implanted Medical Devices
Read more: FDA In Brief: FDA Continues to Monitor the Effects of Magnets in Consumer Electronics on Implanted Medical Devices
US FDA News: Scentsational Soaps & Candles, Inc. Voluntarily Expands Nationwide Recall of Scented Hand Sanitizers Due to the Presence of Methanol (Wood Alcohol), Benzene and Acetaldehyde
Scentsational Soaps & Candles, Inc., has voluntarily expanded its April 27 recall of scented Hand Sanitizers to include three lots of Goose Creek HAND SANITIZER (NDC 75078-004) + Aloe and one lot of COCO TKO HAND SANITIZER in 3.38 and 3.4 fluid ounce spray bottles, respectively, to the consumer leve
Read more: Scentsational Soaps & Candles, Inc. Voluntarily Expands Nationwide Recall of Scented Hand Sanitizers Due to the Presence of Methanol (Wood Alcohol), Benzene and Acetaldehyde
Read more: Scentsational Soaps & Candles, Inc. Voluntarily Expands Nationwide Recall of Scented Hand Sanitizers Due to the Presence of Methanol (Wood Alcohol), Benzene and Acetaldehyde
US FDA News: Abbott (formally known as “St. Jude Medical”) Recalls Assurity™ and Endurity™ Pacemakers for Potential Moisture Ingress Causing Electrical Short and Reduced Battery Life
Assurity™ and Endurity™ implantable pacemakers correct bradycardia. Moisture may enter some devices, causing electrical problems and shorter battery life.
Read more: Abbott (formally known as “St. Jude Medical”) Recalls Assurity™ and Endurity™ Pacemakers for Potential Moisture Ingress Causing Electrical Short and Reduced Battery Life
Read more: Abbott (formally known as “St. Jude Medical”) Recalls Assurity™ and Endurity™ Pacemakers for Potential Moisture Ingress Causing Electrical Short and Reduced Battery Life
US FDA News: Global Sanitizers Issues Voluntary Nationwide Recall of Medically Minded Hand Sanitizer Due to Presence of Undeclared Methanol
Las Vegas, NV, Global Sanitizers is voluntarily recalling 50 thousand units of Medically Minded hand sanitizers, lot numbers: E212020 & E082020 Best Buy of 5/21/2022 to the user/consumer level. FDA analysis has found the product to contain methanol.
Read more: Global Sanitizers Issues Voluntary Nationwide Recall of Medically Minded Hand Sanitizer Due to Presence of Undeclared Methanol
Read more: Global Sanitizers Issues Voluntary Nationwide Recall of Medically Minded Hand Sanitizer Due to Presence of Undeclared Methanol
Pharma Reviews: Himachal's pharma industry lifeline for neighbouring states during pandemic: CM Thakur
The pharmaceutical industry of Himachal Pradesh has emerged as a ... of hydroxychloroquine (HCQ) were shipped from India to the United States, ...
Read more: Himachal's pharma industry lifeline for neighbouring states during pandemic: CM Thakur
Read more: Himachal's pharma industry lifeline for neighbouring states during pandemic: CM Thakur
Pharma Reviews: 'Compulsory licensing' to alleviate shortage may be counterproductive: FICCI
The Federation of Indian Chambers of Commerce & Industry (FICCI) has ... The Indian Drug Manufacturers' Association (IDMA) had on Wednesday ...
Read more: 'Compulsory licensing' to alleviate shortage may be counterproductive: FICCI
Read more: 'Compulsory licensing' to alleviate shortage may be counterproductive: FICCI
Pharma Reviews: Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN Labs
Drug firm Eli Lilly and Company on Thursday said it has inked voluntary licensing agreements with three Indian drug firms --. Torrent Pharmaceuticals.
Read more: Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN Labs
Read more: Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN Labs
Pharma Reviews: British officials to warn over Indian coronavirus variant: reports
PHE had no immediate comment on the reports. Follow and connect with us on Twitter, Facebook, Linkedin · Industry · Mutations · variants.
Read more: British officials to warn over Indian coronavirus variant: reports
Read more: British officials to warn over Indian coronavirus variant: reports
Pharma Reviews: Coronavirus India News Live Updates: Lockdown imposed in Bihar extended till May 25, says CM ...
The Indian Drug Manufacturers' Association (IDMA) on May 12 urged the Centre to issue compulsory licences to pharmaceutical companies so that they ...
Read more: Coronavirus India News Live Updates: Lockdown imposed in Bihar extended till May 25, says CM ...
Read more: Coronavirus India News Live Updates: Lockdown imposed in Bihar extended till May 25, says CM ...
Wednesday, May 12, 2021
Pharma Reviews: A Pandemic Came Calling – and India Was No Longer the World's Pharmacy
On the other side of the world, mRNA vaccine manufacturers Moderna Therapeutics and Pfizer/BioNTech are galloping ahead with plans to manufacture ...
Read more: A Pandemic Came Calling – and India Was No Longer the World's Pharmacy
Read more: A Pandemic Came Calling – and India Was No Longer the World's Pharmacy
Pharma Reviews: Zydus Cadila to sell its India focused animal health biz for Rs 2921 cr to Multiples, RARE
Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies. "Simple waiving of patents for vaccines is not enough ...
Read more: Zydus Cadila to sell its India focused animal health biz for Rs 2921 cr to Multiples, RARE
Read more: Zydus Cadila to sell its India focused animal health biz for Rs 2921 cr to Multiples, RARE
Pharma Reviews: How Nutraceuticals Industry can contribute to India's GDP
Pharmaceuticals export from India stood at US $16.3 billion in FY20. Pharmaceutical export includes bulk drugs, intermediates, drug formulations, ...
Read more: How Nutraceuticals Industry can contribute to India's GDP
Read more: How Nutraceuticals Industry can contribute to India's GDP
US FDA News: Dibar Nutricional S. de R.L. De C.V. Issues Voluntary Nationwide Recall of DIBAR Labs Hand Sanitizer Due to the Presence of Methanol (Wood Alcohol)
Morelia, Michoacán, Mexico, Dibar Nutricional S. de R.L. De C.V. (“Dibar”) is voluntarily recalling 27 lots of DIBAR Labs Hand Sanitizer packaged in 8oz (8-53090-00301-3 UPC) and 16 oz (8-53090-00302-0 UPC) fluid ounce bottles, respectively, to the consumer level. (See products listed below in Tabl
Read more: Dibar Nutricional S. de R.L. De C.V. Issues Voluntary Nationwide Recall of DIBAR Labs Hand Sanitizer Due to the Presence of Methanol (Wood Alcohol)
Read more: Dibar Nutricional S. de R.L. De C.V. Issues Voluntary Nationwide Recall of DIBAR Labs Hand Sanitizer Due to the Presence of Methanol (Wood Alcohol)
US FDA News: Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication
The FDA is providing recommendations for certain high-risk populations may be more vulnerable to potential adverse health effects of mercury exposure from dental amalgam.
Read more: Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication
Read more: Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication
Pharma Reviews: Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies
“Global Pharma companies owe at least this much to mankind,” it further said. The IDMA said that the shortages of Remdesivir in India is a wake-up call.
Read more: Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies
Read more: Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies
Pharma Reviews: Pharma companies urge govt to issue compulsory licenses to make covid-19 drugs
The Indian Drug Manufacturers' Association (IDMA) on Wednesday urged the government to use World Trade Organization's (WTO) provisions to ...
Read more: Pharma companies urge govt to issue compulsory licenses to make covid-19 drugs
Read more: Pharma companies urge govt to issue compulsory licenses to make covid-19 drugs
US FDA News: Medtronic, Inc. Recalls Instructions for Use and Patient Manual for HeartWare HVAD System to Update Information about Carrying Case, Driveline Cover, and Controller Power-Up Issues
The HeartWare HVAD System is used in patients with heart failure. The Instructions for Use and Patient Manual Will be Updated to Address System Issues.
Read more: Medtronic, Inc. Recalls Instructions for Use and Patient Manual for HeartWare HVAD System to Update Information about Carrying Case, Driveline Cover, and Controller Power-Up Issues
Read more: Medtronic, Inc. Recalls Instructions for Use and Patient Manual for HeartWare HVAD System to Update Information about Carrying Case, Driveline Cover, and Controller Power-Up Issues
Pharma Reviews: Big relief for import-dependent Indian pharma as Sichuan Airlines resumes cargo services
Chengdu is one of the major sources for pharmaceutical raw material for Indian drug manufacturers. India is sourcing almost 70 per cent of drug ...
Read more: Big relief for import-dependent Indian pharma as Sichuan Airlines resumes cargo services
Read more: Big relief for import-dependent Indian pharma as Sichuan Airlines resumes cargo services
Pharma Reviews: India's Gigantic Profitable Company Does not Belong to Business or Finance; Astonishing. How ...
Indian pharmaceutical company was the largest manufacturer of vaccines in the world, and for dealing in profits the company might have gauged their ...
Read more: India's Gigantic Profitable Company Does not Belong to Business or Finance; Astonishing. How ...
Read more: India's Gigantic Profitable Company Does not Belong to Business or Finance; Astonishing. How ...
Pharma Reviews: Govt intervenes to maintain supply chain from China, keep med prices in check
Anticipating the flight suspension will continue, pharma manufacturers in ... Ashok Kumar Madan, executive director of Indian Drug Manufacturers ...
Read more: Govt intervenes to maintain supply chain from China, keep med prices in check
Read more: Govt intervenes to maintain supply chain from China, keep med prices in check
Pharma Reviews: Gainers & Losers: 10 stocks that moved most on May 11
Pharmaceutical sales tracked by AIOCD surged 51.5 percent last month as the second wave of COVID-19 overwhelmed India. April 2021 has the ...
Read more: Gainers & Losers: 10 stocks that moved most on May 11
Read more: Gainers & Losers: 10 stocks that moved most on May 11
Tuesday, May 11, 2021
Pharma Reviews: India's Cipla to make and sell Eli Lilly's baricitinib to treat Covid-19
Aside from remdesivir and tocilizumab, the company also offers antiviral drug favipiravir, used to treat patients with moderate to mild Covid-19. Last week ...
Read more: India's Cipla to make and sell Eli Lilly's baricitinib to treat Covid-19
Read more: India's Cipla to make and sell Eli Lilly's baricitinib to treat Covid-19
Pharma Reviews: 'High Time Govt Opens Doors To Enable Capable Vaccine Manufacturers To Produce Vaccines ...
The petition states that there are more than 3,000 pharma companies in India, who together run 10,500 manufacturing facilities. Out of this, the public ...
Read more: 'High Time Govt Opens Doors To Enable Capable Vaccine Manufacturers To Produce Vaccines ...
Read more: 'High Time Govt Opens Doors To Enable Capable Vaccine Manufacturers To Produce Vaccines ...
Pharma Reviews: COVID drug shortage: Experts discuss supply scenario, raw material price rise
Sudarshan Jain, secretary-general of Indian Pharmaceutical Alliance (IPA) and Ashok Madan, executive director of Indian Drug Manufacturers' ...
Read more: COVID drug shortage: Experts discuss supply scenario, raw material price rise
Read more: COVID drug shortage: Experts discuss supply scenario, raw material price rise
Pharma Reviews: Buy Now Sell Now
EP121 - Nifty-50 trades in the red; Pharma, Realty take the lead | Buy Now Sell Now ... The Indian equity market witnessed a negative start and it was ...
Read more: Buy Now Sell Now
Read more: Buy Now Sell Now
Pharma Reviews: Sun Pharma share hits new 52-week high after firm wins licence to make Covid-19 drug
The three Indian drugmakers - Cipla Ltd, Lupin Ltd, and Sun Pharma will collaborate with Lilly to manufacture and distribute Baricitinib in India. The drug ...
Read more: Sun Pharma share hits new 52-week high after firm wins licence to make Covid-19 drug
Read more: Sun Pharma share hits new 52-week high after firm wins licence to make Covid-19 drug
Pharma Reviews: Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
And last week, India received its first batch of Sputnik V vaccines. Russia has signed a deal with an Indian pharma company Dr Reddy's to distribute ...
Read more: Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
Read more: Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
Pharma Reviews: India's most profitable large company is a familiar, if unexpected, one
There were 18 pharma companies in this ₹5,000 crore set. The next best was Macleods Pharmaceuticals, with a net margin of 28%. MORE FROM THIS ...
Read more: India's most profitable large company is a familiar, if unexpected, one
Read more: India's most profitable large company is a familiar, if unexpected, one
Pharma Reviews: Market HIGHLIGHTS: Sensex snaps 4-day rally, ends below 49200; Nifty at 14850; Kotak Mahindra ...
Share Market News Today | Sensex, Nifty, Share Prices HIGHLIGHTS: Domestic equity market benchmarks BSE ... Power Grid Corporation of India, Sun Pharma, Ultratech Cement, SBI, which were up in the range of 0.75-4 per cent.
Read more: Market HIGHLIGHTS: Sensex snaps 4-day rally, ends below 49200; Nifty at 14850; Kotak Mahindra ...
Read more: Market HIGHLIGHTS: Sensex snaps 4-day rally, ends below 49200; Nifty at 14850; Kotak Mahindra ...
Pharma Reviews: Stocks To Watch: HUL, Indian Overseas Bank, InterGlobe Aviation, PNB
Non-Nifty Earnings: Aarti Industries, Alembic, Andhra Paper, BASF India, Bliss GVS Pharma, Dishman Carbogen Amcis, Firstsource Solutions, Granules ...
Read more: Stocks To Watch: HUL, Indian Overseas Bank, InterGlobe Aviation, PNB
Read more: Stocks To Watch: HUL, Indian Overseas Bank, InterGlobe Aviation, PNB
Pharma Reviews: Allow more pharma firms to make vaccines: Delhi CM Kejriwal to Centre
According to the chief minister, the two companies producing vaccines in India are capable of manufacturing 60-70 million doses a month, and at this ...
Read more: Allow more pharma firms to make vaccines: Delhi CM Kejriwal to Centre
Read more: Allow more pharma firms to make vaccines: Delhi CM Kejriwal to Centre
Pharma Reviews: India: Waiver Under TRIPS Agreement Needed More Urgently Now
During initial days of onset of Corona virus globally India pharmaceutical industry not only did pioneering research but also ramped up production ...
Read more: India: Waiver Under TRIPS Agreement Needed More Urgently Now
Read more: India: Waiver Under TRIPS Agreement Needed More Urgently Now
Pharma Reviews: Explained: Intellectual property waiver for Covid-19 vaccines
The US support for an IP waiver stems from a proposal by India and South ... In a joint letter to US President Joe Biden in March, pharma companies ...
Read more: Explained: Intellectual property waiver for Covid-19 vaccines
Read more: Explained: Intellectual property waiver for Covid-19 vaccines
US FDA News: Yamtun7 Issues Voluntary Nationwide Recall of Poseidon Platinum 3500 Due to the Presence of Undeclared Tadalafil and Sildenafil
Delray Beach, Florida, Yamtun7 is voluntarily recalling all lots of Poseidon Platinum 3500 to the consumer level. FDA analysis has found the product to contain undeclared tadalafil and sildenafil. Tadalafil and sildenafil are drugs known as phosphodiesterase (PDE-5) inhibitors found in FDA approved
Read more: Yamtun7 Issues Voluntary Nationwide Recall of Poseidon Platinum 3500 Due to the Presence of Undeclared Tadalafil and Sildenafil
Read more: Yamtun7 Issues Voluntary Nationwide Recall of Poseidon Platinum 3500 Due to the Presence of Undeclared Tadalafil and Sildenafil
Pharma Reviews: Vaccines are sensitive products, maintaining robust cold-chain system utmost important: Sanjay ...
The Indian pharmaceutical industry in coordination with the Government of India made sure that medicines and vaccines reach the individuals during ...
Read more: Vaccines are sensitive products, maintaining robust cold-chain system utmost important: Sanjay ...
Read more: Vaccines are sensitive products, maintaining robust cold-chain system utmost important: Sanjay ...
Pharma Reviews: Acasti Pharma to buy Indian origin Grace Therapeutics
Through a release dated May 7, 2021, Acasti said that the firm would acquire Grace's pipeline of drug candidates targeting important unmet medical ...
Read more: Acasti Pharma to buy Indian origin Grace Therapeutics
Read more: Acasti Pharma to buy Indian origin Grace Therapeutics
Pharma Reviews: Vivimed Labs Bags Indian Govt Nod To Manufacture, Market Favipiravir
Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from ...
Read more: Vivimed Labs Bags Indian Govt Nod To Manufacture, Market Favipiravir
Read more: Vivimed Labs Bags Indian Govt Nod To Manufacture, Market Favipiravir
US FDA News: FDA In Brief: FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products
FDA finalizes guidance to discuss how to identify the elements in an application that are considered necessary to assure product quality.
Read more: FDA In Brief: FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products
Read more: FDA In Brief: FDA Finalizes Guidance with Internationally Harmonized Recommendations to Further Support Safe, High-Quality Human Drug Products
Pharma Reviews: Market Live Updates: Indices trade lower dragged by IT, pharma; oil & gas stocks gain
Traders were concerned after Fitch Ratings stated that there are increasing indications that India's latest wave of Covid-19 infections would increase ...
Read more: Market Live Updates: Indices trade lower dragged by IT, pharma; oil & gas stocks gain
Read more: Market Live Updates: Indices trade lower dragged by IT, pharma; oil & gas stocks gain
Monday, May 10, 2021
Pharma Reviews: Pharma industry faces shortage of raw material
... imbalance between India and China for supplies of raw material of medicines to oversight of successive Indian governments to the pharma sector.
Read more: Pharma industry faces shortage of raw material
Read more: Pharma industry faces shortage of raw material
Pharma Reviews: Patent waiver necessary
This is called compulsory licensing wherein a company can be forced to ... an Indian pharma company which in 1993 developed and sold a drug at ...
Read more: Patent waiver necessary
Read more: Patent waiver necessary
Pharma Reviews: Market HIGHLIGHTS: Sensex ends higher for 4th day, Nifty above 14900, Sun Pharma, Kotak Bank ...
Indian share market indices BSE Sensex and Nifty 50 ended April 2021 on a negative note, falling up to 2.5 per cent on the back of rising COVID-19 ...
Read more: Market HIGHLIGHTS: Sensex ends higher for 4th day, Nifty above 14900, Sun Pharma, Kotak Bank ...
Read more: Market HIGHLIGHTS: Sensex ends higher for 4th day, Nifty above 14900, Sun Pharma, Kotak Bank ...
US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic
The FDA expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to include adolescents down to 12 years of age.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic
US FDA News: Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® Product Samples Due to Improper Storage Temperature Conditions
Novo Nordisk is voluntarily recalling 1,468 product samples listed in the table below of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy®, to the consumer level. These products are being recalled because they were stored at temperatures below storage requirements. This recall only impacts product
Read more: Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® Product Samples Due to Improper Storage Temperature Conditions
Read more: Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® Product Samples Due to Improper Storage Temperature Conditions
US FDA News: FDA In Brief: FDA to Hold Meeting of its Vaccines and Related Biological Products Advisory Committee to Discuss Pediatric Use of COVID-19 Vaccines
The FDA will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on June 10, 2021, to discuss pediatric use of COVID1-9 vaccines.
Read more: FDA In Brief: FDA to Hold Meeting of its Vaccines and Related Biological Products Advisory Committee to Discuss Pediatric Use of COVID-19 Vaccines
Read more: FDA In Brief: FDA to Hold Meeting of its Vaccines and Related Biological Products Advisory Committee to Discuss Pediatric Use of COVID-19 Vaccines
Pharma Reviews: DAK seeks compulsory licensing for Covid-19 vaccine, drugs
“The drug which costs Rs 40,000 for a single dose is manufactured by Switzerland based pharma company Roche and is marketed by Cipla in India.
Read more: DAK seeks compulsory licensing for Covid-19 vaccine, drugs
Read more: DAK seeks compulsory licensing for Covid-19 vaccine, drugs
Pharma Reviews: Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
Indian Pharma Market (IPM) sales for April 2021 showed an unprecedented 51.5 per cent growth year on year (YoY). Adjusting for the low base effect ...
Read more: Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
Read more: Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
Pharma Reviews: Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly's COVID-19 drug
US pharmaceutical major Eli Lilly and Company (Lilly) has issued royalty-free, non-exclusive voluntary licenses to Indian generic firms Cipla Ltd, ...
Read more: Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly's COVID-19 drug
Read more: Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly's COVID-19 drug
Pharma Reviews: FabiFlu numero uno in Indian pharma market, show April sales data
Daily fresh cases touched 401,993 on April 30. FabiFlu-numero-uno-in-Indian-pharma-market-show-. FabiFlu is an oral antiviral drug, ...
Read more: FabiFlu numero uno in Indian pharma market, show April sales data
Read more: FabiFlu numero uno in Indian pharma market, show April sales data
Pharma Reviews: Coronavirus India News Live Updates: States continue to face vaccine shortage; 17 crore doses ...
The Chinese pharmaceutical company in a stock filing at night on May 9 said the companies will invest up to $100 million each to set up the venture, the ...
Read more: Coronavirus India News Live Updates: States continue to face vaccine shortage; 17 crore doses ...
Read more: Coronavirus India News Live Updates: States continue to face vaccine shortage; 17 crore doses ...
Pharma Reviews: Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India
Drug firm Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with Indian drug firms -- Sun Pharma, Cipla and Lupin ...
Read more: Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India
Read more: Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India
Pharma Reviews: Market LIVE: Sensex gains 350 points; Nifty around 14950; pharma, metal lead
Indian equities opened in the green on Monday tailing global markets. Sensex was around 350 points higher at over 49,560. Nifty topped the 14,900 ...
Read more: Market LIVE: Sensex gains 350 points; Nifty around 14950; pharma, metal lead
Read more: Market LIVE: Sensex gains 350 points; Nifty around 14950; pharma, metal lead
Subscribe to:
Comments (Atom)